Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebeccamycin Analog Schedules in Advanced NSCLC
NCT00006017Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- May 2000
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of becatecarin in non-small cell lung cancer (NSCLC), sponsored by Case Comprehensive Cancer Center. Started May 2000; status: completed.
02
Drugs
becatecarin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006017.